Publications by Dr Helen Marr - ePrints

Browsing publications by Dr Helen Marr.

Newcastle Authors	Title	Year
Erhan Aptullahoglu Mohammed Howladar Dr Jonathan Wallis Dr Helen Marr Professor Julie Irving et al.	Targeting the MDM2-p53 Interaction with Siremadlin: A Promising Therapeutic Strategy for Treating TP53 Wild-Type Chronic Lymphocytic Leukemia	2025
Erhan Aptullahoglu Dr Jonathan Wallis Dr Helen Marr Dr Elaine Willmore Professor John Lunec et al.	SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia	2023
Dr Carmela Ciardullo Dr Jonathan Wallis Dr Helen Marr Dr Nicholas Bown Dr Elaine Willmore et al.	Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition	2023
Dr Helen Marr	Richter transformation of chronic lymphocytic leukaemia: a British Society for Haematology Good Practice Paper	2022
Dr Carmela Ciardullo Erhan Aptullahoglu Dr Laura Woodhouse Dr Wei-Yu Lin Dr Jonathan Wallis et al.	Non-genotoxic MDM2 inhibition selectively induces pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells	2019
Dr Paul Sinclair Dr Helen Blair Dr Sarra Ryan Dr Lars Buechler Joanna Cheng et al.	Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21	2018
Dr Nicola Sunter Dr Andrew Hall Dr Tryfonia Mainou-Fowler Professor Graham Jackson Dr Helen Marr et al.	Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia	2017
Dr Elaine Willmore Dr Aaron Ions Gardner Dr Susan Tudhope Belinda Murtani Jessica Caffry et al.	Novel small molecule IKK alpha inhibitors inhibit non- canonical NF-kappa B signaling and survival of primary CLL cells	2015
Dr Helen Marr Dr Luke Gaughan Dr Susan Tudhope Professor James Allan	Regulation of CD38 in IRF4 in Chronic Lymphocytic Leukaemia	2015